Dupilumab cuts exacerbations in late-onset asthma
(HealthDay)—Dupilumab is associated with significantly reduced severe exacerbation rates in patients with late-onset asthma with or without fixed airway obstruction, according to a study presented at
Updated on: April 15,2024
18

Dupilumab cuts exacerbations in late-onset asthma
(HealthDay)—Dupilumab is associated with significantly reduced severe exacerbation rates in patients with late-onset asthma with or without fixed airway obstruction, according to a study presented at
Updated on:April 15,2024
18
